Aveo Oncology Patents – Insights & Stats (Updated 2023)

Aveo Oncology has a total of 365 patents globally, out of which 149 have been granted. Of these 365 patents, more than 38% patents are active. The USA is where Aveo Oncology has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, the USA seems to be the main focused R&D center of Aveo Oncology and is also the origin country of the firm.

Aveo Oncology was founded in the year 2001 by Kenneth E. Weg, Lynda Chin, Paul Hurley and Ronald A. DePinho. The company is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics. It has been acquired by LG Chem.

Do read about some of the most popular patents of Aveo Oncology which have been covered by us in this article and also you can find Aveo Oncology patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Aveo Oncology patent portfolio.

How many patents does Aveo Oncology have?

Aveo Oncology has a total of 365 patents globally. These patents belong to 70 unique patent families. Out of 365 patents, 141 patents are active.

How Many Patents did Aveo Oncology File Every Year?

Aveo Oncology Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAveo Oncology Applications FiledAveo Oncology Patents Granted
202247
2021817
2020411
201998
201866
2017117
201659
20153211
201414
20133711
20123517
20114625

How many Aveo Oncology patents are Alive/Dead?

Worldwide Patents

Aveo Oncology Patent Portfolio

How Many Patents did Aveo Oncology File in Different Countries?

Aveo Oncology Worldwide Patent Filing

Countries in which Aveo Oncology Filed Patents

CountryPatents
United States Of America64
Europe35
Japan28
Australia25
Canada17
Austria12
China12
Korea (South)9
Spain9
Germany9
Hong Kong (S.A.R.)9
Brazil8
Mexico8
Israel7
Singapore5
Norway5
Denmark5
South Africa5
New Zealand5
India5
Argentina5
Philippines4
Indonesia3
Poland3
Russia3
Portugal2
Italy2
Hungary1
Taiwan1
Malta1

Where are Research Centres of Aveo Oncology Patents Located?

R&D Centres of Aveo Oncology

10 Best Aveo Oncology Patents

US8187601B2 is the most popular patent in the Aveo Oncology portfolio. It has received 40 citations so far from companies like Genentech and Affinia Therapeutics.

Below is the list of 10 most cited patents of Aveo Oncology:

Publication NumberCitation Count
US8187601B240
US7649083B230
US20130165337A128
WO2012149014A120
WO2011005273A120
US8481687B219
WO2012003472A118
US7659378B217
WO2016049470A117
WO2011156617A216

What are Aveo Oncology key innovation segments?

What Technologies are Covered by Aveo Oncology?

The chart below distributes patents filed by Aveo Oncology in different countries on the basis of the technology protected in patents. It also represents the markets where Aveo Oncology thinks it’s important to protect particular technology inventions.

R&D Focus: How has Aveo Oncology search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Aveo Oncology?

Related Articles

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.